These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6349458)

  • 1. Making intensified insulin treatment safer.
    Boden G; Hoeldtke RD
    Ann Intern Med; 1983 Aug; 99(2):268-9. PubMed ID: 6349458
    [No Abstract]   [Full Text] [Related]  

  • 2. Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine.
    Cryer PE; Gerich JE
    Diabetes Care; 1983; 6(1):95-9. PubMed ID: 6341018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of beta-adrenergic blockade on glucose homeostasis in insulin-induced hypoglycemia during physiological processes in diabetes mellitus].
    Szelachowska M
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):397-400. PubMed ID: 2255659
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unusual manifestations of the Somogyi phenomenon in a patient with idiopathic hemochromatosis].
    Kop'ev VIu; Golochevskaia VS; Sheptulin AA; Bokeriia OA
    Klin Med (Mosk); 1991 Sep; 69(9):78-9. PubMed ID: 1803162
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.
    Ranjan A
    Dan Med J; 2018 Feb; 65(2):. PubMed ID: 29393039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones.
    Boden G; Reichard GA; Hoeldtke RD; Rezvani I; Owen OE
    N Engl J Med; 1981 Nov; 305(20):1200-5. PubMed ID: 7027041
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man.
    Benson JW; Johnson DG; Palmer JP; Werner PL; Ensinck JW
    J Clin Endocrinol Metab; 1977 Mar; 44(3):459-64. PubMed ID: 838846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemia experienced by insulin-treated diabetics].
    Goldgewicht C; Slama G; Papoz L; Gin H; Soria J; Desplanque N; Tchobroutsky G
    Journ Annu Diabetol Hotel Dieu; 1981; ():247-56. PubMed ID: 7017226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes mellitus. 13. Insulin therapy of diabetes mellitus].
    Michaelis D
    Z Arztl Fortbild (Jena); 1971 Oct; 65(20):1006-13. PubMed ID: 5170112
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When and how to use insulin in the elderly diabetic.
    Shuman CR; Owen OE
    Geriatrics; 1976 Oct; 31(10):75-9. PubMed ID: 964603
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of hypoglycemia-associated autonomic failure in diabetes.
    Cryer PE
    N Engl J Med; 2013 Jul; 369(4):362-72. PubMed ID: 23883381
    [No Abstract]   [Full Text] [Related]  

  • 16. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia in diabetics during Hajj.
    Khan SA; Bhat AR; Khan LA
    Saudi Med J; 2002 Dec; 23(12):1548. PubMed ID: 12518212
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.
    White NH; Skor DA; Cryer PE; Levandoski LA; Bier DM; Santiago JV
    N Engl J Med; 1983 Mar; 308(9):485-91. PubMed ID: 6337335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IV insulin during acute cerebral infarction in diabetic patients.
    Bruno A; Saha C; Williams LS; Shankar R
    Neurology; 2004 Apr; 62(8):1441-2. PubMed ID: 15111697
    [No Abstract]   [Full Text] [Related]  

  • 20. Muscarinic cholinergic antagonism does not enhance recovery from hypoglycemia in IDDM.
    Hvidberg A; Cryer PE
    Diabetes Care; 1995 Mar; 18(3):404-7. PubMed ID: 7555487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.